BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19372822)

  • 1. The promise and challenge of anti-HIV cellular immunity.
    Borrow P; Turnbull EL
    Curr Opin HIV AIDS; 2006 Jul; 1(4):277-85. PubMed ID: 19372822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the possibilities for T-cell-based AIDS vaccines.
    Garber DA; Feinberg MB
    Curr Opin HIV AIDS; 2006 Jul; 1(4):314-22. PubMed ID: 19372827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV vaccines: can mucosal CD4 T cells be protected?
    Mattapallil JJ; Roederer M
    Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of antibody-mediated protection against HIV infection.
    Sattentau Q
    Curr Opin HIV AIDS; 2008 May; 3(3):368-74. PubMed ID: 19372992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses in primary HIV-1 infection.
    Frost SD; Trkola A; Günthard HF; Richman DD
    Curr Opin HIV AIDS; 2008 Jan; 3(1):45-51. PubMed ID: 19372943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral reservoirs and HIV-specific immunity.
    Blankson JN
    Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment interruption to boost specific HIV immunity in acute infection.
    Kaufmann DE; Walker BD
    Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and function of protective T cell immune responses in HIV.
    Betts MR; Harari A
    Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.
    Turnbull EL; Wong M; Wang S; Wei X; Jones NA; Conrod KE; Aldam D; Turner J; Pellegrino P; Keele BF; Williams I; Shaw GM; Borrow P
    J Immunol; 2009 Jun; 182(11):7131-45. PubMed ID: 19454710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responses in primary HIV-1 infection.
    Streeck H; van Bockel D; Kelleher A
    Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
    Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
    AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus.
    Friedrich TC; Watkins DI
    Curr Opin HIV AIDS; 2008 May; 3(3):393-8. PubMed ID: 19372996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immunization in HIV infection.
    Autran B; Kinloch-de Loes S; Katlama C
    Curr Opin HIV AIDS; 2006 Jul; 1(4):323-9. PubMed ID: 19372828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capturing viral diversity for in-vitro test reagents and HIV vaccine immunogen design.
    Brander C; Self S; Korber B
    Curr Opin HIV AIDS; 2007 May; 2(3):183-8. PubMed ID: 19372885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
    Debre P; Costagliola D; Legrand R; Vieillard V
    Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute HIV infection: it takes more than guts.
    Mattapallil JJ; Roederer M
    Curr Opin HIV AIDS; 2006 Jan; 1(1):10-5. PubMed ID: 19372777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical primate studies of HIV-1-envelope-based vaccines: towards human clinical trials.
    Heeney JL
    Curr Opin HIV AIDS; 2006 Jul; 1(4):336-43. PubMed ID: 19372830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute HIV-1 infection: are we getting there?
    Cellerai C; Little SJ; Loes SK
    Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.